NCT00672113View on ClinicalTrials.gov

Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

August 31, 2004

Conditions
Hypertension
Interventions
DRUG

Adalat (Nifedipine, BAYA1040)

Nifedipine GITS 30 mg followed by Coracten 30 mg then back to nifedipine GITS 30 mg

DRUG

Coracten

Coracten 30 mg followed by nifedipine GITS 30 mg then back to Coracten 30 mg

Trial Locations (1)

CB2 2XY

Cambridge

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY